Medite Cancer Diagnostics Inc (MDIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Medite Cancer Diagnostics Research and Development Expense (Quarterly): 0.142M for Sept. 30, 2018
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 0.142M |
| June 30, 2018 | 0.258M |
| March 31, 2018 | 0.305M |
| December 31, 2017 | 0.011M |
| September 30, 2017 | 0.423M |
| June 30, 2017 | 0.329M |
| March 31, 2017 | 0.425M |
| December 31, 2016 | 0.391M |
| September 30, 2016 | 0.305M |
| June 30, 2016 | 0.421M |
| March 31, 2016 | 0.36M |
| December 31, 2015 | 0.453M |
| September 30, 2015 | 0.222M |
| June 30, 2015 | 0.341M |
| March 31, 2015 | 0.262M |
| December 31, 2014 | 0.481M |
| September 30, 2014 | 0.317M |
| June 30, 2014 | 0.246M |
| March 31, 2014 | 0.199M |
| December 31, 2013 | 0.409M |
| September 30, 2013 | 0.056M |
| June 30, 2013 | 0.285M |
| March 31, 2013 | 0.081M |
| December 31, 2012 | 0.071M |
| September 30, 2012 | 0.082M |
| Date | Value |
|---|---|
| June 30, 2012 | 0.109M |
| March 31, 2012 | 0.073M |
| December 31, 2011 | 0.066M |
| September 30, 2011 | 0.056M |
| June 30, 2011 | 0.064M |
| March 31, 2011 | 0.051M |
| December 31, 2010 | -0.002M |
| September 30, 2010 | 0.083M |
| June 30, 2010 | 0.065M |
| March 31, 2010 | 0.065M |
| December 31, 2009 | -0.385M |
| September 30, 2009 | 0.087M |
| June 30, 2009 | 0.10M |
| March 31, 2009 | 0.113M |
| December 31, 2008 | 0.203M |
| September 30, 2008 | 0.332M |
| June 30, 2008 | 0.508M |
| March 31, 2008 | 0.809M |
| December 31, 2007 | 0.821M |
| September 30, 2007 | 0.565M |
| June 30, 2007 | 0.817M |
| March 31, 2007 | 0.396M |
| December 31, 2006 | 0.368M |
| September 30, 2006 | 0.193M |
| June 30, 2006 | 0.227M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median